Provided by Tiger Trade Technology Pte. Ltd.

Verastem

7.44
-0.1100-1.46%
Post-market: 7.500.0600+0.81%19:46 EDT
Volume:4.50M
Turnover:33.69M
Market Cap:673.79M
PE:-3.08
High:7.84
Open:7.58
Low:7.40
Close:7.55
52wk High:10.82
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:2.38
T/O Rate:6.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:13.48
PE(LYR):-2.46

Loading ...

Verastem Oncology Doses First Patient in Target-D 203 Phase 2 Registration-Directed Trial of Vs-7375 Oral Kras G12d (on/off) Inhibitor for Kras G12d-Mutated Metastatic Colorectal Cancer

THOMSON REUTERS
·
Jul 29

Verastem - Initiates Treatment in All Three Target-D Phase 2 Trials

THOMSON REUTERS
·
Jul 29

Press Release: Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026

Dow Jones
·
Jul 23

Verastem Oncology to Report Q2 2026 Financial Results in Conference Call

Reuters
·
Jul 23

Verastem doses first patient in TARGET-D 202 Phase 2 trial

TIPRANKS
·
Jul 23

Verastem Oncology Doses First Patient in Target-d 202 Phase 2 Registration-directed Trial of Vs-7375 for Kras G12d-mutated Advanced Non-small Cell Lung Cancer

THOMSON REUTERS
·
Jul 23

These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why

Benzinga_recent_news
·
Jul 22

Verastem’s KRAS G12D Trial Targets a New Niche in Colorectal Cancer

TIPRANKS
·
Jul 18

Verastem is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Verastem Oncology Grants 399,750 Rsus, Sets New-hire Stock Option Exercise Price at $4.1

Reuters
·
Jul 03

Verastem Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Verastem is Maintained at Buy by BTIG

Dow Jones
·
Jul 03

Cardiff, Verastem, Fluence, Quantum-Si, Opera Insider Shock

TIPRANKS
·
Jun 27

Top Verastem Executives Quietly Cash Out in Fresh Stock Moves

TIPRANKS
·
Jun 25

Verastem's VS-7375 Update Reiterates Potential in US Patients, RBC Says

MT Newswires Live
·
Jun 24

Verastem (VSTM) Gets a Buy from Alliance Global Partners

TIPRANKS
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: Palvella Therapeutics (PVLA), Verastem (VSTM)

TIPRANKS
·
Jun 24

Verastem Price Target Maintained with a $18.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 24

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Verastem (VSTM) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 24